EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipidomic Profiling Reveals Distinct Molecular Signatures Across Clinical Subtypes of Myasthenia Gravis

Yufei Song, Die Dai, Min Cao, Rongrong Li, Jiaru Liu, Min Zhang, Yuqing Chen, Ruimin Tian iD, Peiyu Liu, Xiaoting Peng, Jiayi Huang, Qilin Fang und 3 weitere

Metabolites · 19.08.2026 · 16 (8) · 589

DOI: 10.3390/metabo16080589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 19.08.2026. Verfasst von Yufei Song und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second…. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Pearl River Talent Plan-Innovation and Entrepreneurship Team Introduction Project, NIEHS NIH HHS, the Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Myasthenia gravis (MG) is an immune-mediated neuromuscular disorder for which antibody-based assays have limited sensitivity, particularly in double-seronegative MG (dsNMG), highlighting the need for complementary biomarkers. Given their roles in immune regulation, membrane integrity, and metabolic stress responses, lipids represent promising candidates for biomarker discovery.

Methods

We designed a prospective case–control study and systematically stratified 68 patients with myasthenia gravis (MG) according to clinical classification and autoantibody status. Using LC–MS/MS, we quantified 824 lipids in 136 serum samples collected from these patients and 68 healthy controls. The analyzed subtypes included ocular MG (OMG), generalized MG (GMG), acetylcholine receptor antibody-positive MG (AChR-MG), and dsNMG. Differential lipid analysis, correlation network construction, KEGG pathway enrichment, and multivariable logistic regression were performed. Diagnostic and subtype prediction models were developed using LASSO with 10 × 10 repeated cross-validation and interpreted using Shapley Additive exPlanations (SHAP) analysis. A longitudinal follow-up analysis was conducted to assess dynamic associations between lipid signatures and disease activity.

Results

In total, 240 lipids were significantly altered in MG compared with controls. Lipids distinguishing GMG from OMG were enriched in ether lipid metabolism, necroptosis, and sphingolipid signaling pathways. AChR-MG and dsNMG shared lipid networks related to membrane remodeling and signaling regulation, whereas dsNMG exhibited marked elevations in acylcarnitines and bile acid-related metabolites, potentially reflecting a distinct phenotype characterized by altered energy metabolism. The lipid-based model achieved an AUC of 0.917 for distinguishing MG from controls, and AUCs of 0.77 and 0.71 for differentiating AChR-MG from dsNMG and GMG from OMG, respectively. Longitudinal analyses showed that SM(d18:1/23:0) and Cer(d24:1/18:0(2OH)) displayed dynamic changes consistent with disease activity.

Conclusions

Serum lipidomics revealed subtype-specific metabolic features of MG, with stable disease-associated remodeling and dynamic sphingolipid changes potentially reflecting disease activity. By integrating systematic clinical and antibody-based subtype stratification with longitudinal follow-up, this study supports lipidomics as a complementary tool for precision diagnosis and disease stratification, particularly in antibody-negative dsNMG.

Schlagwörter

Stichwörter der Autor:innen

biomarkersdiagnostic challengelipidomic signaturemachine learningmyasthenia gravis

Autor:innen und Institutionen

  • State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Gu…
  • Chinese Medicine Guangdong Laboratory (Hengqin Laboratory), Hengqin 519031, China.
  • School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.

ORCID-Profile: Ruimin Tian

Förderung

  • the Pearl River Talent Plan-Innovation and Entrepreneurship Team Introduction Project
  • NIEHS NIH HHS
  • the Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine
  • the State Key Laboratory of Traditional Chinese Medicine Syndrome Project
  • the National Key Research and Development Program of China
  • Pearl River Talent Plan—Innovation and Entrepreneurship Team Introduction Project
  • National Key Research and Development Program of China
  • National Administration of Traditional Chinese Medicine

Zitieren

APA

Song, Y., Dai, D., Cao, M., Li, R., Liu, J., Zhang, M., Chen, Y., Tian, R., Liu, P., Peng, X., Huang, J., Fang, Q., Dong, B., Pang, B., & Liu, L. (2026). Lipidomic Profiling Reveals Distinct Molecular Signatures Across Clinical Subtypes of Myasthenia Gravis. Metabolites, 16(8), 589. https://doi.org/10.3390/metabo16080589

Vancouver

Song Y, Dai D, Cao M, Li R, Liu J, Zhang M, et al. Lipidomic Profiling Reveals Distinct Molecular Signatures Across Clinical Subtypes of Myasthenia Gravis. Metabolites. 2026;16(8):589. doi:10.3390/metabo16080589

BibTeX
@article{Song2026,
  author = {Song, Yufei and Dai, Die and Cao, Min and Li, Rongrong and Liu, Jiaru and Zhang, Min and Chen, Yuqing and Tian, Ruimin and Liu, Peiyu and Peng, Xiaoting and Huang, Jiayi and Fang, Qilin and Dong, Beibei and Pang, Biyi and Liu, Liang},
  title = {Lipidomic Profiling Reveals Distinct Molecular Signatures Across Clinical Subtypes of Myasthenia Gravis},
  journal = {Metabolites},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {589},
  doi = {10.3390/metabo16080589}
}
Kostenlos starten →